Contributors |
|
xiii | |
Preface |
|
xvii | |
|
Chapter 1 Biomedical techniques in cellular and molecular diagnostics: Journey so far and the way forward |
|
|
1 | (12) |
|
|
|
|
|
1.1 Biomedical imaging technology |
|
|
1 | (9) |
|
|
2 | (1) |
|
|
3 | (1) |
|
1.1.3 Magnetic resonance imaging |
|
|
4 | (1) |
|
1.1.4 Positron emission tomography scans |
|
|
5 | (1) |
|
1.1.5 Single-photon emission computerized tomography |
|
|
6 | (1) |
|
|
6 | (1) |
|
1.1.7 Hyperspectral imaging |
|
|
7 | (1) |
|
1.1.8 Photoacoustic (PA) imaging |
|
|
8 | (1) |
|
1.1.9 Near-infrared spectroscopy (NIRS) |
|
|
8 | (1) |
|
1.1.10 Microscopy imaging |
|
|
9 | (1) |
|
|
10 | (3) |
|
|
10 | (3) |
|
Chapter 2 Role of CT scan in medical and dental imaging |
|
|
13 | (20) |
|
|
|
|
|
2.1 Introduction to computed tomography |
|
|
13 | (1) |
|
2.2 Benefits and uses of CT scan |
|
|
14 | (1) |
|
2.3 Issues regarding CT scan |
|
|
14 | (1) |
|
2.4 Technical parameters and clinical applications |
|
|
15 | (3) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
2.5 Advancement in CT scans |
|
|
18 | (2) |
|
|
18 | (1) |
|
2.5.2 Iterative reconstruction |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
20 | (1) |
|
2.6 Application of CBCT in dentistry |
|
|
20 | (7) |
|
2.6.1 CBCT in dental implantology |
|
|
20 | (2) |
|
2.6.2 CBCT in oral and maxillofacial surgery |
|
|
22 | (1) |
|
2.6.3 CBCT in endodontics |
|
|
23 | (2) |
|
2.6.4 Applications in orthodontics |
|
|
25 | (1) |
|
2.6.5 Pediatric dentistry |
|
|
25 | (1) |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
27 | (6) |
|
|
27 | (6) |
|
Chapter 3 Ultrasonography Technology and applications in clinical radiology |
|
|
33 | (12) |
|
|
|
|
|
33 | (1) |
|
|
33 | (2) |
|
3.3 Interaction between ultrasound and matter |
|
|
35 | (3) |
|
|
35 | (1) |
|
|
35 | (2) |
|
|
37 | (1) |
|
3.4 Fundamental technology |
|
|
38 | (2) |
|
3.4.1 Piezoelectricity and production of ultrasound |
|
|
38 | (2) |
|
3.5 Instrumentation and image formation |
|
|
40 | (2) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
3.5.5 Image processor/scan converter |
|
|
42 | (1) |
|
|
42 | (1) |
|
3.6 Image representation and clinical application |
|
|
42 | (2) |
|
3.6.1 Modes of ultrasound |
|
|
42 | (2) |
|
|
44 | (1) |
|
|
44 | (1) |
|
Chapter 4 Magnetic resonance imaging: Basic principles and advancement in clinical and diagnostics approaches in health care |
|
|
45 | (22) |
|
|
|
|
|
|
45 | (1) |
|
4.2 Basic principles of MRI |
|
|
46 | (2) |
|
|
48 | (3) |
|
|
48 | (2) |
|
4.3.2 Gradient and shim coils |
|
|
50 | (1) |
|
4.3.3 Radiofrequency coils (RFC) |
|
|
50 | (1) |
|
|
51 | (1) |
|
4.4 The basic concept of image acquisition and formation in an MRI system |
|
|
51 | (3) |
|
4.5 Contrast agents used in MRI |
|
|
54 | (2) |
|
4.5.1 Magnetic susceptibility |
|
|
54 | (1) |
|
4.5.2 Molecular tumbling/Larmor frequency and dipole interactions: A rationale of contrast |
|
|
55 | (1) |
|
4.5.3 Nature of contrast agents |
|
|
55 | (1) |
|
4.5.4 Classification of contrast agents |
|
|
55 | (1) |
|
|
56 | (1) |
|
4.7 MRI contrast agents: based on the specific area of interest |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
|
57 | (1) |
|
4.6.6 Safety concerns associated with the use of contrast agents |
|
|
57 | (1) |
|
4.8 Types of MRI and their applications |
|
|
58 | (2) |
|
|
58 | (1) |
|
4.8.2 Functional magnetic resonance imaging (fMRI) |
|
|
58 | (1) |
|
4.8.3 Diffusion tensor imaging |
|
|
59 | (1) |
|
4.8.4 Arterial spin labeling (ASL) |
|
|
59 | (1) |
|
4.8.5 Neuromelanin-sensitive MRI |
|
|
60 | (1) |
|
4.8.6 Quantitative susceptibility mapping |
|
|
60 | (1) |
|
4.9 Current clinical applications of MRI in cardiovascular diseases |
|
|
60 | (2) |
|
4.9.1 Assessment of left and right ventricular volumes and mass, as well as systolic function |
|
|
61 | (1) |
|
4.9.2 Assessment of myocardial viability and myocardial perfusion |
|
|
61 | (1) |
|
4.9.3 Evaluation of congenital heart disease with shunt calculation |
|
|
61 | (1) |
|
4.9.4 Evaluation and follow-up of valvular disease |
|
|
61 | (1) |
|
4.9.5 Evaluation of pericardial disease |
|
|
61 | (1) |
|
4.9.6 Evaluation of aortic disease |
|
|
62 | (1) |
|
4.9.7 Evaluation of cardiac masses |
|
|
62 | (1) |
|
|
62 | (1) |
|
4.9.9 Arrhythmogenic right ventricular cardiomyopathy |
|
|
62 | (1) |
|
4.10 Role of MRI in diagnosis, staging, and disease evaluation in cancers |
|
|
62 | (1) |
|
4.11 Contraindications and limitations of MRI |
|
|
63 | (1) |
|
|
63 | (4) |
|
|
64 | (3) |
|
Chapter 5 Current update about instrumentation and utilization of PET-CT scan in oncology and human diseases |
|
|
67 | (18) |
|
|
|
|
|
67 | (1) |
|
5.2 PET imaging and instrumentation |
|
|
68 | (3) |
|
|
68 | (1) |
|
5.2.2 Acquisition and image reconstruction: 2D versus 3D |
|
|
68 | (1) |
|
|
69 | (1) |
|
5.2.4 Attenuation correction |
|
|
69 | (1) |
|
|
70 | (1) |
|
5.2.6 Image reconstruction methods |
|
|
70 | (1) |
|
5.2.7 The need for PET screening in diverse cancers |
|
|
70 | (1) |
|
5.3 Clinical significances of PET in cancer |
|
|
71 | (7) |
|
5.3.1 Clinical endorsement by PET-CT |
|
|
72 | (3) |
|
5.3.2 Detailed staging with the help of PET |
|
|
75 | (1) |
|
5.3.3 PET-CT as support therapy |
|
|
76 | (2) |
|
5.4 Role of PET in the diagnosis of human diseases other than cancer |
|
|
78 | (1) |
|
|
78 | (7) |
|
|
79 | (6) |
|
Chapter 6 Revolutionizing medical diagnosis with SPECT imaging: Clinical applications of a nuclear imaging technology |
|
|
85 | (20) |
|
|
|
|
|
|
|
85 | (1) |
|
6.1.1 Historical origin and development of single photon emission tomography |
|
|
85 | (1) |
|
6.2 Components and working of SPECT imaging device |
|
|
86 | (4) |
|
|
90 | (5) |
|
6.3.1 SPECT/CT for benign conditions of the bone |
|
|
90 | (1) |
|
6.3.2 SPECT/CT in neuroendocrine neoplasms |
|
|
90 | (3) |
|
6.3.3 Radionuclide bone imaging for staging malignant metastases |
|
|
93 | (2) |
|
6.4 Targeted imaging of prostate cancer with radioligands |
|
|
95 | (2) |
|
6.5 SPECT imaging using 67ga-citrate SPECT/CT in lymphoma |
|
|
97 | (1) |
|
6.6 SPECT imaging: nononcologic diseases |
|
|
98 | (1) |
|
|
99 | (6) |
|
|
100 | (5) |
|
Chapter 7 Mammography--sentinel of breast cancer management |
|
|
105 | (10) |
|
|
|
|
|
105 | (1) |
|
7.2 Evolution of mammography |
|
|
106 | (1) |
|
7.3 Dissecting the mammography machine |
|
|
107 | (2) |
|
7.4 How a mammogram is captured |
|
|
109 | (1) |
|
7.5 Deciphering a mammogram |
|
|
109 | (2) |
|
|
111 | (1) |
|
7.7 Recent advances in mammography |
|
|
111 | (1) |
|
7.7.1 Contrast-enhanced mammography |
|
|
111 | (1) |
|
7.7.2 Three-dimensional mammography |
|
|
111 | (1) |
|
7.7.3 Photon counting mammography |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
112 | (3) |
|
|
112 | (3) |
|
Chapter 8 Hyperspectral Imaging: Current and Potential Clinical Applications |
|
|
115 | (16) |
|
|
|
|
|
|
115 | (1) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
8.7 Use externally to the human body |
|
|
119 | (1) |
|
8.7.1 Monitoring of patients in critical care |
|
|
119 | (1) |
|
8.7.2 Diagnosis of skin cancers |
|
|
119 | (1) |
|
8.7.3 Diagnosis and monitoring of other skin lesions |
|
|
119 | (1) |
|
8.7.4 Screening for arthritis |
|
|
120 | (1) |
|
8.7.5 Screening for vascular diseases |
|
|
120 | (1) |
|
|
120 | (2) |
|
8.8.1 Upper and lower gastrointestinal endoscopy |
|
|
120 | (1) |
|
8.8.2 Endoscopic retrograde chonlangiopancreatogram (ERCP) and choledochoscopy |
|
|
121 | (1) |
|
8.8.3 Video-assisted thoracic surgery (VATS) |
|
|
121 | (1) |
|
8.8.4 Functional endoscopic sinus surgery and neuroendoscopy |
|
|
122 | (1) |
|
|
122 | (1) |
|
8.9 Applications in surgery |
|
|
122 | (3) |
|
8.9.1 Gastrointestinal anastomoses |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
124 | (1) |
|
8.9.5 Transplant surgeries |
|
|
124 | (1) |
|
8.9.6 Colorectal cancer surgeries |
|
|
125 | (1) |
|
8.10 Applications for imaging the eye |
|
|
125 | (1) |
|
|
125 | (1) |
|
|
125 | (1) |
|
8.11.1 Models of wound healing |
|
|
125 | (1) |
|
8.11.2 HSI-based light microscopy |
|
|
125 | (1) |
|
8.11.3 Confocal microscopy |
|
|
126 | (1) |
|
|
126 | (5) |
|
|
126 | (5) |
|
Chapter 9 PA Imaging: A promising tool for targeted therapeutic implications in Cancer |
|
|
131 | (30) |
|
Samudyata C. Prabhuswamimath |
|
|
|
131 | (4) |
|
|
132 | (2) |
|
|
134 | (1) |
|
|
135 | (4) |
|
9.2.1 Vascular Endothelial Growth Factor |
|
|
136 | (1) |
|
9.2.2 VEGF and Permeability |
|
|
137 | (1) |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
139 | (4) |
|
9.3.1 Epithelial to Mesenchymal Transition (EMT) |
|
|
140 | (2) |
|
9.3.2 Mitogen-activated protein kinase (MAPK) pathway |
|
|
142 | (1) |
|
|
143 | (4) |
|
|
144 | (1) |
|
9.4.2 Single-walled carbon nanotubes (SWCNTs) |
|
|
145 | (1) |
|
9.4.3 Semiconductor nanoparticles |
|
|
146 | (1) |
|
9.4.4 Organic nanoparticles |
|
|
146 | (1) |
|
9.4.5 Inorganic magnetic nanoparticles |
|
|
146 | (1) |
|
9.4.6 Graphene nanomaterial |
|
|
147 | (1) |
|
9.5 Biomedical applications of PAI in cancer |
|
|
147 | (14) |
|
|
149 | (12) |
|
Chapter 10 Near-infrared spectroscopy: An important noninvasive and sensitive tool for point-of-care biosensing application |
|
|
161 | (24) |
|
|
|
|
|
|
|
161 | (1) |
|
10.2 Fundamentals of near-infrared spectroscopy |
|
|
162 | (1) |
|
10.2.1 Basic divisions in infrared region |
|
|
162 | (1) |
|
10.2.2 Molecular overtones and near-infrared spectra |
|
|
163 | (1) |
|
10.3 Instrumentation of near-infrared spectrophotometer |
|
|
163 | (4) |
|
|
163 | (3) |
|
10.3.2 Sampling techniques and measuring methods in near-infrared Spectroscopy |
|
|
166 | (1) |
|
10.4 Analyzing an infrared spectrum |
|
|
167 | (2) |
|
10.4.1 Data treatment of an infrared spectrum |
|
|
168 | (1) |
|
10.5 General applications of near-infrared spectroscopy |
|
|
169 | (2) |
|
10.5.1 Non invasive technology in clinical chemistry |
|
|
170 | (1) |
|
10.6 Nanomaterial-assisted near-infrared spectroscopy-based biosensing |
|
|
171 | (14) |
|
10.6.1 Semiconductor quantum dots (QDs) |
|
|
173 | (2) |
|
10.6.2 Carbon nanomaterials |
|
|
175 | (1) |
|
10.6.3 Plasmonic nanoparticles and nanoshells |
|
|
176 | (1) |
|
10.6.4 Dye encapsulating nanoparticles |
|
|
177 | (2) |
|
|
179 | (6) |
|
Chapter 11 Advances in Microscopy and Their Applications in Biomedical Research |
|
|
185 | (21) |
|
|
|
|
|
11.1 Microscopy as an integral part of biomedical research |
|
|
185 | (1) |
|
11.2 Photon-based imaging |
|
|
186 | (8) |
|
11.2.1 Fluorescence microscopy: Working, advancements, and biomedical applications |
|
|
187 | (3) |
|
11.2.2 Confocal microscopy: Working, advancements, and biomedical applications |
|
|
190 | (4) |
|
11.3 Automated imaging workstations for optical microscopy |
|
|
194 | (2) |
|
11.4 Near-field scanning optical microscopy (NSOM): Principle and biomedical applications |
|
|
196 | (1) |
|
11.5 Electron-based imaging: electron microscopy (EM) |
|
|
197 | (6) |
|
11.5.1 Scanning electron microscope: Working and biomedical applications |
|
|
198 | (3) |
|
11.5.2 Transmission electron microscope: Working and biomedical applications |
|
|
201 | (2) |
|
11.6 Resolution for photon-based and electron-based microscopes |
|
|
203 | (1) |
|
|
204 | (2) |
References |
|
206 | (7) |
Index |
|
213 | |